|1.||Spasov, A A: 2 articles (08/2010 - 01/2004)|
|2.||Kucheriavenko, A F: 1 article (08/2010)|
|3.||Salaznikova, O A: 1 article (08/2010)|
|4.||Anisimov, Vladimir N: 1 article (05/2005)|
|5.||Popovich, Irina G: 1 article (05/2005)|
|6.||Semenchenko, Anna V: 1 article (05/2005)|
|7.||Spasov, Alexander A: 1 article (05/2005)|
|8.||Egormin, Peter A: 1 article (05/2005)|
|9.||Yashin, Anatoly I: 1 article (05/2005)|
|10.||Tyndyk, Margarita L: 1 article (05/2005)|
05/01/2005 - "Treatment with Diabenol was followed by higher incidence of exophytic and well-differentiated colon tumors as compared with the control rats exposed to the carcinogen alone (76.3% and 50%, and 47.4% and 14.7%, respectively). "
05/01/2005 - "The treatment with Diabenol inhibited spontaneous tumor incidence and increased the mammary tumor latency in these mice. "
01/01/2004 - "The effect of new antidiabetic drug Diabenol [9-diethylaminoethyl-2,3-dihydroimidazo-(1,2alpha) benzimidazol dihydrochloride] on life span and spontaneous tumor incidence in NMRI and transgenic HER-2/neu mice was studied. "
01/01/2004 - "[Effect of antidiabetic drug diabenol on parameters of biological age, life span and tumor development in NMRI and HER-2/neu mice]."
01/01/2004 - "The treatment with diabenol inhibited spontaneous tumor incidence (mammary gland and lymphomas mainly) and increased the mammary tumor latency. "
|2.||Neoplasm Metastasis (Metastasis)
|4.||Experimental Diabetes Mellitus
|1.||1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
|3.||Hypoglycemic Agents (Hypoglycemics)